A recent study shows that people at low genetic risk for attention deficit hyperactivity disorder (ADHD) are not only less likely to have the disorder, they also have better than expected economic, health and behavioral outcomes in later life.
Year
Clinical trial for Ebola vaccine developed at UW–Madison underway in Japan
As of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan. Fifteen healthy young men* will receive two doses of the experimental vaccine. If the first group tolerates the vaccine, an additional group of up to 20 volunteers will receive a higher dose of the vaccine.
UW-Madison brain scan studies seek to pinpoint signs of Alzheimer’s
Waisman Center investigator Brad Christian and Waisman Center affiliates Sterling Johnson and Barbara Bendlin were featured in a Nov. 26 Wisconsin State
Journal article this week about Alzheimer’s research. The article is a part of a series on Alzheimer’s called “Fading away: Wisconsin’s dementia crisis,” which chronicles the doubling rate of dementia patients in Wisconsin.
Time-to-degree improves again, setting record
Undergraduates at the University of Wisconsin–Madison are taking less time to complete their degrees, setting a record on a key measure of student success. The average time-to-degree for 2018-19 bachelor’s degree recipients was 3.96 elapsed calendar years, the lowest since the university began actively tracking the measure in the 1980s and the first time the number has dropped below four years, according to the university’s Office of Academic Planning and Institutional Research.
In Wisconsin, 3 in 5 people with Down syndrome diagnosed with dementia by age 55
Not so many years ago, people with Down syndrome rarely survived to middle age. Many died young due to heart problems associated with the congenital condition.
Today, advances in treatment have allowed them to live longer, healthier lives.
Leann Smith DaWalt, PhD, becomes UCEDD director
Leann Smith DaWalt, PhD, a longtime Waisman Center investigator, began her appointment as the director of the University Center for Excellence in Developmental Disabilities (UCEDD) on Oct. 14. She succeeds Bill MacLean, PhD, who retired …
Whole Exome Sequencing Illuminates Genetic Condition
If you ask David Seamans what his favorite thing to do is, he’ll pause thoughtfully for a moment before responding, “Everything.” He really does mean everything
21st century medicine helps Amish deal with rare, inherited illnesses
There is no car in the driveway, neither phone nor electricity in the house. Handmade clothes dry on the line. It’s fall 2018, and La Farge physician James DeLine has brought us to talk with Barbara and Daniel Hochstetler, part of the large Amish population in Wisconsin’s Driftless Region.
New funding for Down syndrome research and biobank
The Waisman Center is one of 25 recipients to receive funding through a National Institutes of Health (NIH) grant that focuses on advancing research on Down syndrome. The grant is part of the NIH Investigation …
Joan Ershler, PhD, longtime Waisman Early Childhood Program (WECP) director retires
After 27 years as the director of the Waisman Early Childhood Program (WECP), Joan Ershler, PhD, retired in early September 2019. The WECP is a model inclusive early childhood program with a developmentally diverse enrollment serving …